An investigational treatment
for APOL1-mediated kidney disease (AMKD).
Here is a quick checklist to see if you might qualify for this study
• You are between 18 and 67 years old
• You have increased protein levels in your urine
• You carry 2 APOL1 variants OR are willing to have a genetic test done to find
out if you carry them